News

Take part in the 4th edition of the Transatlantic Exchanges dedicated to radioligand therapies

Gustave Roussy and the Dana-Farber Cancer Institute (Boston, United States) are organising the fourth edition of the Transatlantic Exchange oncology conference on 19 March 2025 at the Hyatt Regency Paris Étoile hotel. The theme will be “Radiopharmaceutical Therapy Meets Oncology.”

Published on

Transatlantic Exchange

Gustave Roussy and the Dana-Farber Cancer Institute (Boston, United States) are organising the fourth edition of the Transatlantic Exchange oncology conference on 19 March 2025 at the Hyatt Regency Paris Étoile hotel. The theme will be “Radiopharmaceutical Therapy Meets Oncology.”

Free registration (in-person or virtual): https://events.medscapelive.org/website/82041/.

Transatlantic Exchange

After the 2024 edition dedicated to liquid biopsy, organised in Boston, the Franco-American oncology conference Transatlantic Exchange returns this year to Paris to discuss the latest advances related to radioligand therapies.

Physician-researchers will share their expertise on theranostics for early cancer detection and characterisation, the latest clinical advances concerning innovative radiopharmaceuticals, and the prospects for the development of radioligand treatments.

A radioligand treatment, or radionuclide therapy, is an innovative approach in oncology that combines a drug specifically targeting tumour cells with a radioactive isotope. This therapy delivers a radiation dose directly to cancer cells while sparing healthy tissues, offering increased precision and new perspectives for treating numerous cancers.

This edition of the Transatlantic Exchange will be chaired by Professor Toni Choueiri, Medical Director of International Strategic Initiatives and Director of the Lank Center for Genitourinary Oncology at the Dana-Farber Cancer Institute and Harvard Medical School, as well as by Professor Karim Fizazi, Head of the International Academic Network at Gustave Roussy and Head of the Genitourinary Cancer Committee at the Institute.

Registrations open

The conference, organised with the support of the Institut Servier and Medscape Medical Affairs, is free and open to healthcare professionals interested in oncology.

Registration on the website: https://events.medscapelive.org/website/82041/.

 

Last news

  • Two photon-counting CT scanners now equip Gustave Roussy's imaging department

    Since September 2026, Gustave Roussy's Department of Medical Imaging has been equipped with a second photon-counting CT scanner, delivering higher image resolution while reducing the doses of X-rays and contrast agent administered to patients. This technology recently enabled the Institute to perform an iodine-free pulmonary CT angiogram, a world first.

    Photographie du scanner à comptage photonique
  • Prevention and screening: getting ahead of lung cancer

    To mark Thoracic Cancer Awareness Month and Tobacco-Free Month, two campaigns focusing on lung cancer, Gustave Roussy highlights its initiatives to advance prevention and screening among people at increased risk. Since its creation in 2021, the Institute’s Interception Lung programme has welcomed more than 900 participants, supporting them to stop smoking and offering personalised screening for the disease.

    Photographie : patient effectuant un scanner thoracique et équipes soignantes
  • Gustave Roussy Meets His Audience

    As part of its awareness-raising and fundraising efforts, Gustave Roussy is currently conducting a door-to-door outreach campaign in several towns in Val-de-Marne (Fresnes, Vitry-sur-Seine, Nogent-sur-Marne, Bry-sur-Marne, Le Kremlin-Bicêtre) from Monday through Saturday, 1:30 p.m. to 8:00 p.m.

    Deux personnes en charge de la collecte porte-à-porte
  • Mens November: Take care of your jewelry its precious!

    November is the month dedicated to raising awareness and promoting prevention of male cancers, which include prostate, testicular, and penile cancers. The goal is to raise public awareness of these diseases—which account for approximately 63,000 new cases in France each year—and to encourage men to perform testicular self-exams, a simple step that can help detect a lump, the nature of which must then be determined through further medical examinations. Gustave Roussy has extensive expertise in the treatment of male cancers, particularly through its Genitourinary Oncology Committee, which is deeply involved in research on these diseases. 

    Visuel fixe campagne novembre masculin